首页> 外文会议>Conference on microfluidics, bioMEMS, and medical microsystems XV >Microfluidic devices for stem-cell cultivation, differentiation and toxicity testing
【24h】

Microfluidic devices for stem-cell cultivation, differentiation and toxicity testing

机译:用于干细胞栽培,分化和毒性测试的微流体装置

获取原文

摘要

The development of new drugs is time-consuming, extremely expensive and often promising drug candidates fail in late stages of the development process due to the lack of suitable tools to either predict toxicological effects or to test drug candidates in physiologically relevant environments prior to clinical tests. We therefore try to develop diagnostic multi-organ microfluidic chips based on patient specific induced pluripotent stem cell (iPS) technology to explore liver dependent toxic effects of drugs on individual human tissues such as liver or kidney cells. Based initially on standardized microfluidic modules for cell culture, we have developed integrated microfluidic devices which contain different chambers for cell/tissue cultivation. The devices are manufactured using injection molding of thermoplastic polymers such as polystyrene or cyclo-olefin polymer. In the project, suitable surface modification methods of the used materials had to be explored. We have been able to successfully demonstrate the seeding, cultivation and further differentiation of modified iPS, as shown by the use of differentiation markers, thus providing a suitable platform for toxicity testing and potential tissue-tissue interactions.
机译:新药的发展是耗时的,极其昂贵,往往有前途的毒品候选人由于缺乏适当的工具来预测毒理学效应或在临床试验之前在生理相关环境中测试药物候选者而导致的发展过程的后期失败。因此,我们试图基于患者特异性诱导多能干细胞(IPS)技术开发诊断多器官微流体芯片,以探讨药物对肝脏或肾细胞等个体组织对药物的肝依赖性毒性作用。最初基于用于细胞培养的标准化微流体模块,我们开发了含有不同腔室的集成微流体装置,用于细胞/组织培养。这些装置是使用热塑性聚合物如聚苯乙烯或环烯烃聚合物的注射成型制造的。在该项目中,必须探索合适的使用材料的表面改性方法。我们已经能够成功地证明改性IP的播种,培养和进一步分化,如使用分化标志物所示,从而为毒性测试和潜在的组织组织相互作用提供合适的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号